Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bittinger

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Clinical Gastroenterology|August 1, 1990
Intramural pancreatic pseudocyst in the gastric wall: diagnosis by sonography and ultrasound-guided punctureI Koop, H Mönnikes, C Fehmann, et al.
Current Biology : CB|December 14, 2004
Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteinsMark A Bittinger, Elizabeth McWhinnie, Jodi Meltzer, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Journal of Neuro-Oncology|October 22, 2011
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopyWhitney B Pope, Robert M Prins, M Albert Thomas, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Cancer Immunology Research|July 24, 2019
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor ImmunitySangeetha Palakurthi, Mari Kuraguchi, Sima J Zacharek, et al.
Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.
JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Clinical Gastroenterology|August 1, 1990
Intramural pancreatic pseudocyst in the gastric wall: diagnosis by sonography and ultrasound-guided punctureI Koop, H Mönnikes, C Fehmann, et al.
Current Biology : CB|December 14, 2004
Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteinsMark A Bittinger, Elizabeth McWhinnie, Jodi Meltzer, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Journal of Neuro-Oncology|October 22, 2011
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopyWhitney B Pope, Robert M Prins, M Albert Thomas, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Cancer Immunology Research|July 24, 2019
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor ImmunitySangeetha Palakurthi, Mari Kuraguchi, Sima J Zacharek, et al.
Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.
JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Pageof 6